Kingsview Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.59M Sell
41,379
-1,872
-4% -$208K 0.08% 265
2025
Q1
$4.85M Buy
43,251
+1,237
+3% +$139K 0.09% 223
2024
Q4
$3.88M Buy
42,014
+22,091
+111% +$2.04M 0.08% 246
2024
Q3
$1.67M Buy
19,923
+1,628
+9% +$136K 0.04% 416
2024
Q2
$1.26M Sell
18,295
-27
-0.1% -$1.85K 0.03% 450
2024
Q1
$1.34M Sell
18,322
-406
-2% -$29.7K 0.03% 429
2023
Q4
$1.52M Sell
18,728
-1,841
-9% -$149K 0.05% 348
2023
Q3
$1.54M Sell
20,569
-18,612
-48% -$1.39M 0.06% 339
2023
Q2
$3.02M Sell
39,181
-7,481
-16% -$577K 0.12% 186
2023
Q1
$3.87M Buy
46,662
+12,949
+38% +$1.07M 0.16% 134
2022
Q4
$2.89M Buy
33,713
+11,587
+52% +$995K 0.13% 191
2022
Q3
$1.37M Buy
22,126
+3,342
+18% +$206K 0.06% 274
2022
Q2
$1.16M Sell
18,784
-4,173
-18% -$258K 0.06% 327
2022
Q1
$1.36M Buy
22,957
+4,978
+28% +$296K 0.06% 313
2021
Q4
$1.31M Buy
17,979
+1,046
+6% +$75.9K 0.05% 318
2021
Q3
$1.18M Buy
16,933
+1,014
+6% +$70.8K 0.06% 325
2021
Q2
$1.1M Buy
15,919
+2,137
+16% +$148K 0.05% 351
2021
Q1
$916K Buy
13,782
+695
+5% +$46.2K 0.05% 352
2020
Q4
$762K Sell
13,087
-3,468
-21% -$202K 0.06% 340
2020
Q3
$1.05M Buy
16,555
+2,242
+16% +$142K 0.09% 215
2020
Q2
$1.1M Buy
14,313
+1,819
+15% +$140K 0.11% 189
2020
Q1
$934K Buy
12,494
+8,444
+208% +$631K 0.13% 188
2019
Q4
$263K Buy
+4,050
New +$263K 0.03% 390
2018
Q4
Sell
-2,635
Closed -$203K 360
2018
Q3
$203K Buy
+2,635
New +$203K 0.04% 339
2018
Q2
Sell
-3,423
Closed -$258K 326
2018
Q1
$258K Buy
+3,423
New +$258K 0.06% 273
2017
Q3
Sell
-3,274
Closed -$232K 283
2017
Q2
$232K Sell
3,274
-1,681
-34% -$119K 0.12% 219
2017
Q1
$337K Buy
+4,955
New +$337K 0.2% 156